arrow
M

Mutlu Hayran

hacettepe university
H指数:37
被引数:4,143

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The clinical characteristics of patients with congenital nephrotic syndrome secondary to NPHS1 mutation: Is nephrectomy still a therapeutic option for selected cases? (may, 10.1007/s00467-025-06774-6, 2025)

先天性肾病综合征患者(继发于NPHS1突变)的临床特征:对于特定病例,肾切除术是否仍是一种治疗选择?(2025年5月,10.1007/s00467-025-06774-6)

2025-05-090
OA
The clinical characteristics of patients with congenital nephrotic syndrome secondary to NPHS1 mutation: Is nephrectomy still a therapeutic option for selected cases?

先天性肾病综合征继发于NPHS1基因突变患者的临床特征:对于特定病例,肾切除术是否仍是一种治疗选择?

2025-04-231
OA
Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine plus nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study
2020-03-3012
OAAI